GEORGE TOWN: Smith + Nephew, a United Kingdom-based orthopaedic implant manufacturer, is investing in a production facility in Batu Kawan to support its customers in the global market.
Penang Chief Minister Chow Kon Yeow said this would be the company’s first manufacturing facility in South-East Asia.
“The new facility will generate over 800 jobs in the next five years.
“The plant, which will be 250,000 sq ft, is expected to ship out its first batch of implants before the end of 2022.
“Construction work will begin in early 2020, ” he said.
Chow spoke after witnessing the exchange of documents on the sale of the leasehold land in Batu Kawan to Smith + Nephew.
Penang Development Corp (PDC) general manager Datuk Mohd Bazid Abd Kahar exchanged documents with Smith +Nephew vice-president (manufacturing network strategy) Ross Macken.
Also present was investPenang director Datuk Seri Lee Kah Choon.
Macken declined to disclose amount of investment.
Meanwhile, Lee said Smith + Nephew was one of the world’s top-30 medical device companies by revenue.
“Penang is a clear leader in non-glove medical devices, particularly in implants and surgical instruments, therapeutic products, diagnostic equipment, and non-latex disposables.
“There are currently 56 medical technology device companies in Penang with world-renowned names that include B.Braun, Abbott Laboratories, Boston Scientific, Canon Medical Systems, Haemonetics, Integer Holdings, Tecomet, Japan Lifeline, Pentax Medical and Ambu.
“The medical technology industry in Penang is a sizeable and growing source of high-quality, high-technology jobs that make a difference in the lives of people worldwide, ” Lee added.